Health Guide
Compound Library
Plain-English summaries: what it is, what it was studied for, safety and regulatory status, plus mixing and dosing charts.
An investigational once-weekly medicine from Eli Lilly that activates three hormone receptors: GIP, GLP-1 and glucagon.
An investigational combination of an amylin analogue and a GLP-1 receptor agonist.
A 16-amino-acid fragment of human growth hormone studied for fat metabolism.
An investigational long-acting amylin analogue for weight management.
A pill that raises a man's own testosterone by signaling the brain to make more LH and FSH.
An investigational once-weekly peptide that activates both GLP-1 and glucagon receptors, studied for obesity and fatty liver disease (MASH).
An experimental metabolic compound, not a peptide, widely used in labs to activate AMPK, the cell's energy sensor.
An investigational once-weekly amylin receptor agonist being developed by Lilly for obesity.
A two-amino-acid peptide studied for effects on immune signaling.